Sign In
29 Nov 2010 13:06
ο»Ώ
Β
Β
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
Β
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | ARK THERAPEUTICS GROUP PLC | |||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||||||||
Β An acquisition or disposal of voting rights | Β x | |||||||||
Β An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||||||||
Β An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||||||||
Β An event changing the breakdown of voting rights | ||||||||||
Β Other (please specify): |
| |||||||||
3. Full name of person(s) subject to the notification obligation: Β | Β Smith & Williamson Holdings Limited | |||||||||
4. Full name of shareholder(s) (if different from 3.): Β | Β See section 9 | |||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: Β | Β 23.11.2010 | |||||||||
6. Date on which issuer notified: Β | 26.11.2010 | |||||||||
7. Threshold(s) that is/are crossed or reached: Β | 10% | |||||||||
8. Notified details: | ||||||||||
A: Voting rights attached to shares Β | ||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | ||||||
Direct | Direct | Indirect | Direct | Indirect | ||||||
Ordinary GB0034251727 | Β 20,849,600 | 20,849,600 | 20,949,600 | 10.01% | ||||||
Β
B: Financial Instruments | ||||||
Resulting situation after the triggering transaction Β | ||||||
Type of financialinstrument | Exerciseprice | Expirationdate | Exercise/Conversionperiod | Number of votingrights instrumentrefers to | % of voting rights Β | |
Β N/A | Nominal | Delta Β | ||||
Total (A+B) Β | ||||||
Number of voting rights | Percentage of voting rights | |||||
20,949,600 | 10.01% | |||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||||||
Smith and Williamson Nominees Limited, a subsidiary of Smith and Williamson Investment Management Limited, a subsidiary of Smith and Williamson Holdings Limited - 6,224,600 shares Β Royal Bank of Scotland as custodian for Smith & Williamson Fund Administration Ltd, a subsidiary of Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Limited - 4,000,000 shares Β BNP Paribas as custodian for Smith and Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Limited - 725,000 shares Β BNP Paribas Securities Services as custodian for Smith & Williamson Investment Management (Ireland) Limited, a subsidiary of Smith & Williamson Holdings Limited - 10,000,000 shares Β | ||||||
Proxy Voting: Β | ||||||
10. Name of the proxy holder: Β | Β N/A | |||||
11. Number of voting rights proxy holder will cease to hold: Β | Β N/A | |||||
12. Date on which proxy holder will cease to hold voting rights: Β | Β N/A | |||||
Β
13. Additional information: Β | |
14. Contact name: Β | Smith and Williamson Holdings Limited |
15. Contact telephone number: Β | 020 7131 4922 |
Β
Β
Β
Β
Follow the stocks
